Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : All-Wales Medicines Strategy Group

Sort by: Newest first Oldest first A-Z Z-A

  • Pre-exposure prophylaxis pills against HIV infection

    Three-year PrEP pilot begins in Wales

    17 JUL 2017 15:44

    A trial has begun in Wales to assess the use of the antiretroviral combination treatment emtricitabine/tenofovir disoproxil (marketed as Truvada) for pre-exposure prophylaxis (PrEP) against HIV infection.

  • vaughan gething wales welsh wales health secretary

    Treatment fund launched in Wales for newly approved drugs

    11 JAN 2017 17:31 By Debbie Andalo

    An £80m new treatment fund to pay for high-cost drugs approved for use on the NHS in Wales has been launched.

  • The Welsh Government office at Llandudno Junction

    Welsh audit body recommends managing medicines plan

    22 DEC 2016 9:10 By Gareth Malson

    The government, the NHS and health bodies should revise the indicators used to compare how different prescribers and organisations use medicines, says a report by the Welsh Audit Office.

  • Vaughan Getting, speaking at the RPS conference

    Gething confirms £80m fund for high-cost medicines in Wales

    19 JUL 2016 16:03

    A central fund worth £80m that will pay for the immediate use of new, high-cost medicines that are approved for use in Wales has been announced by Vaughan Gething, cabinet secretary for health for the Welsh government.

  • Carwyn Jones, First Minister of the National Welsh Assembly

    Welsh Labour pledge to create £80m central fund for high cost drugs Subscription

    15 APR 2016 10:11

    Welsh Labour has pledged to create an £80m central fund to pay for high cost medicines if they retain control of the National Assembly for Wales following the election on 5 May 2016.

  • January 2016: AWMSG approvals Subscription

    18 JAN 2016 13:51

    The All Wales Medicines Strategy Group (AWMSG) has approved the following medicines for use by the NHS in Wales: atazanavir/cobicistat (Evotaz) for adults infected with human immunodeficiency virus-1 (HIV-1); efavirenz (Sustiva) for children aged between 3 months and 3 years who are infected with HIV-1; macitentan (Opsumit) for adults with pulmonary arterial hypertension (only where the approved patient access scheme is used); empagliflozin (Jardiance) for type 2 diabetes. Full details ...

  • December 2015: AWMSG approvals Subscription

    11 JAN 2016 9:44

    The All Wales Medicines Strategy Group (AWMSG) has approved the following medicines for use in NHS Wales: Cetuximab (Erbitux; Merck Serono) for the first-line treatment of epidermal growth factor receptor-expressing, RAS wild-type metastatic colorectal cancer in combination with irinotecan-based chemotherapy or the chemotherapy regimen FOLFOX. Ivacaftor (Kalydeco; Vertex) for cystic fibrosis (CF) in patients aged 6 years and older who have mutations in the CF transmembrane ...

  • December 2015: AWSMG approvals Subscription

    5 JAN 2016 16:18

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): Abasaglar (a biosimilar of insulin glargine; Eli Lilly and Company) for diabetes mellitus in patients aged 2 years and above. Sucroferric oxyhydroxide (Velphoro; Vifor Fresenius Medical Care Renal Pharma) for controlling serum phosphorus levels in adults with chronic kidney disease who are on haemodialysis or peritoneal dialysis where non-calcium based ...

  • AWMSG November medicines approvals Subscription

    20 NOV 2015 16:22

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): Xultophy (insulin degludec and liraglutide) for use with oral antidiabetic drugs to treat adults with type 2 diabetes — it can only be used when oral treatments combined with basal insulin do not provide adequate glycaemic control; Fomicyt (fosfomycin) to treat acute osteomyelitis, complicated urinary tract infections, nosocomial lower respiratory tract infections or bacterial ...

  • August 2015: AWMSG approvals Subscription

    8 SEP 2015 11:07

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): brimonidine gel for treating the symptoms of moderate-to-severe, persistent facial erythema associated with rosacea; Rezolsta (darunavir and cobicistat) for use in combination with other antiretroviral medicines to treat human immunodeficiency virus-1 infection in adults; magnesium aspartate dihydrate for treating and preventing magnesium deficiency in patients aged two ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs